4UT-17990-35880
3 vaccinations
6 coded responses
29 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 721 / AR
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Registered in v-safe
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-04
- 2021-03-05
-
2021-03-07
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Nasal congestion — Feeling: GoodFree text: Cough and nasal stuffiness started last night but had improved todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-03-21
Dose 2 — Pfizer-BioNTech
- 2021-03-21
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-19
- 2021-04-25
- 2021-05-02
- 2021-06-20
-
2021-09-02
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-21
-
2021-10-02
Survey response — day 28, dose 3MedDRA: Fatigue, Pain, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: General aches, pains, fatigue and fever to 102 from hours 24 to 36 after the vaccination. Fatigue continued 72 hours after the vaccination.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-16
-
2021-12-02
Survey response — 3 months, dose 3MedDRA: Adverse reaction, Headache, Productive cough, Sneezing, Viral upper respiratory tract infection — Feeling: FairFree text: Viral URI with productive cough, sneezing, headache and allergy symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Survey response — 6 months, dose 3MedDRA: Body temperature increased, Cough, Dysphonia, Ear pain, Oropharyngeal pain, Rhinorrhoea, Upper-airway cough syndrome — Feeling: FairFree text: Sore throat, hoarseness, cough, earache, sinus drainage at the back of my throat and runny nose. Felt feverish but temperature went to 99.5 degrees.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-02
Survey response — 12 months, dose 3MedDRA: Bronchitis, Cough, Illness — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Non-CoVid viral illness leading to bronchitis and continued cough. On day 3 of antibiotics.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-02
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-09-02 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): No
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Cough and nasal stuffiness started last night but had improved today
Release 9 — day 28, dose 3
Symptoms: General aches, pains, fatigue and fever to 102 from hours 24 to 36 after the vaccination. Fatigue continued 72 hours after the vaccination.
Release 10 — 3 months, dose 3
Symptoms: Viral URI with productive cough, sneezing, headache and allergy symptoms
Release 11 — 6 months, dose 3
Symptoms: Sore throat, hoarseness, cough, earache, sinus drainage at the back of my throat and runny nose. Felt feverish but temperature went to 99.5 degrees.
Release 12 — 12 months, dose 3
Symptoms: Non-CoVid viral illness leading to bronchitis and continued cough. On day 3 of antibiotics.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release